Therefore, potential diagnostic biomarkers have been proposed to improve diagnosis by differentiating AD and psoriasis in patients with psoriasiform dermatitis, namely nitric oxide synthase 2 (NOS2) and CTACK/CCL27 [82,83,84]. The gene discussed is CCL27; the disease is Alzheimer disease.